Influenza Therapeutics Market Analysis, Size, and Share by 2031

Coverage: Influenza Therapeutics Market covers analysis by Therapy Type ( Drug, Vaccines) and Geography , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00009000
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

The Influenza Therapeutics Market is expected to register a CAGR of 9.5% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

This report presents an exhaustive analysis of the Influenza Therapeutics market, providing insight into its current state, growth drivers, challenges, and future outlook. The report further entails aspects such as market size, market share, segmentation by drug type, distribution channel, and region, competitive landscape, and emerging trends. Detailed profiles of leading market players along with their strategies are also covered in the report. This report will be a much-valued resource for the market participants, including pharmaceutical companies, healthcare providers, and investors, who want to have insight into the dynamics of the Influenza Therapeutics market and make a well-informed decision.

Purpose of the Report

The report Influenza Therapeutics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Influenza Therapeutics Market Segmentation

Therapy Type
  • Drug
  • Vaccines

Strategic Insights

Influenza Therapeutics Market Growth Drivers
  • Seasonal Influenza Outbreaks: Among them is the increased occurrence of influenza infections around the globe, especially among frailty groups such as the elderly, children, and immunocompromised patients. New emerging flu strains may have a higher potential to cause severe illness and outbreaks thus leading to a higher demand for effective use of therapeutics.
  • Increasing Healthcare cost: Rising healthcare costs along with growing awareness about preventive measures against influenza have driven the growth of the market.
  • Increased R&D: Research and developments made on creating innovative effective drugs for influenza along with an increase in the geriatric population will drive the market. Strong prospects can be seen within the Influenza Therapeutics market in the near future as there is a lot of emerging trend influencing it.
Influenza Therapeutics Market Future Trends
  • Trend towards combination therapies:
    Combination therapies are emerging more now for the treatment of influenza. Combining antiviral therapies with other treatment methods like immune modulators or even corticosteroids should improve treatment outcomes and significantly reduce recovery times.
  • Increased Emphasis on Personalized Medicine:
    The trend toward personalized medicine is influencing influenza treatment, with a growing emphasis on tailoring treatments based on individual patient characteristics, including viral strain and immune response.
  • Expansion of Over-the-Counter (OTC) Products:
    The expansion of OTC influenza treatments, such as symptom-relief medications (for example, pain relievers, decongestants, and cough suppressants), is increasing access to flu remedies. Consumers become more proactive in managing flu symptoms at home without seeking prescription medications.
Influenza Therapeutics Market Opportunities
  • Development of Universal Influenza Vaccine: The largest opportunity in the flu therapeutics market is the universal influenza vaccine, which has the potential to provide wider protection against influenza strains, including anticipated future variants. It limits the annual vaccination and ensures better prevention of global outbreaks of influenza.
  • Entering Newly Emerging Markets: There is huge scope for the expansion of influenza therapeutics in emerging markets, especially those with high rates of influenza infection and limited access to effective treatments. Improving access to healthcare and awareness in these regions creates a large untapped market.
  • Incorporation with Digital Health Solutions: The integration of influenza therapeutics with digital health solutions like flu-tracking apps or virtual health consultations may offer a unique opportunity for this process. These solutions help to more effectively manage flu outbreaks, potentially allowing for quicker diagnosis and treatment.

Market Report Scope

Key Selling Points

  • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Influenza Therapeutics Market, providing a holistic landscape.
  • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Influenza Therapeutics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.

REGIONAL FRAMEWORK
World Geography

Have a question?

Analyst

Mrinal

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
MARKET PLAYERS
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which are the leading players operating in the Influenza Therapeutics Market?

The leading players of the market are: Abbott, Sanofi SA, CSL Limited, Glaxosmithkline PLC, Daiichi Sankyo Co., Ltd., Roche Holding AG, Biocryst Pharmaceuticals, Inc., Sinovac Biotech Ltd., Mitsubishi Tanabe Pharma Corporation

What are the deliverable formats of the Influenza Therapeutics Market report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report? 

Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

What are the future trends of the Influenza Therapeutics Market?

Trends The future of the Influenza Therapeutics market will be influenced by the following key trends. Major Market Trends include: Development of broad-spectrum antiviral drugs that target multiple influenza strains, thus reducing the need for constant vaccine updates. There is a growing emphasis on innovative drug delivery systems, such as inhaled formulations, which are improving patient compliance and treatment efficacy. Growing concern over rising flu-resistant influenza viruses has motivated the development of combination therapies and host-directed therapies. Overall, the rising demand for effective influenza therapeutics promises significant market opportunities to players, given the growing global elderly population and climate change that modifies disease patterns.

What is the expected CAGR of the Influenza Therapeutics Market?

Influenza Therapeutics Market is expected to grow at a CAGR of 9.5% between 2023-2031

What are the driving factors impacting the Influenza Therapeutics Market?

Drivers in the Influenza Therapeutics market include growth in influenza infections, especially among the vulnerable: the elderly and immunocompromised. The occurrence of new or more virulent influenza forms represents a potent threat, and this will fuel demand for effective influenza therapeutics. Growing healthcare expenditures and increasing awareness of preventive measures for influenza also contribute to the market growth. In addition, the constant research and development for producing new and more potent drugs against influenza coupled with an aging population and growing geriatric segment is likely to drive market growth ahead.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Influenza Therapeutics Market - By Therapy Type
1.3.2 Influenza Therapeutics Market - By Region
1.3.2.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INFLUENZA THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INFLUENZA THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. INFLUENZA THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. INFLUENZA THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. INFLUENZA THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. INFLUENZA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - THERAPY TYPE
7.1. OVERVIEW
7.2. THERAPY TYPE MARKET FORECASTS AND ANALYSIS
7.3. DRUG
7.3.1. Overview
7.3.2. Drug Market Forecast and Analysis
7.4. VACCINES
7.4.1. Overview
7.4.2. Vaccines Market Forecast and Analysis
8. INFLUENZA THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Influenza Therapeutics Market Overview
8.1.2 North America Influenza Therapeutics Market Forecasts and Analysis
8.1.3 North America Influenza Therapeutics Market Forecasts and Analysis - By Therapy Type
8.1.4 North America Influenza Therapeutics Market Forecasts and Analysis - By Countries
8.1.4.1 United States Influenza Therapeutics Market
8.1.4.1.1 United States Influenza Therapeutics Market by Therapy Type
8.1.4.2 Canada Influenza Therapeutics Market
8.1.4.2.1 Canada Influenza Therapeutics Market by Therapy Type
8.1.4.3 Mexico Influenza Therapeutics Market
8.1.4.3.1 Mexico Influenza Therapeutics Market by Therapy Type
8.2. EUROPE
8.2.1 Europe Influenza Therapeutics Market Overview
8.2.2 Europe Influenza Therapeutics Market Forecasts and Analysis
8.2.3 Europe Influenza Therapeutics Market Forecasts and Analysis - By Therapy Type
8.2.4 Europe Influenza Therapeutics Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Influenza Therapeutics Market
8.2.4.1.1 Germany Influenza Therapeutics Market by Therapy Type
8.2.4.2 France Influenza Therapeutics Market
8.2.4.2.1 France Influenza Therapeutics Market by Therapy Type
8.2.4.3 Italy Influenza Therapeutics Market
8.2.4.3.1 Italy Influenza Therapeutics Market by Therapy Type
8.2.4.4 Spain Influenza Therapeutics Market
8.2.4.4.1 Spain Influenza Therapeutics Market by Therapy Type
8.2.4.5 United Kingdom Influenza Therapeutics Market
8.2.4.5.1 United Kingdom Influenza Therapeutics Market by Therapy Type
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Influenza Therapeutics Market Overview
8.3.2 Asia-Pacific Influenza Therapeutics Market Forecasts and Analysis
8.3.3 Asia-Pacific Influenza Therapeutics Market Forecasts and Analysis - By Therapy Type
8.3.4 Asia-Pacific Influenza Therapeutics Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Influenza Therapeutics Market
8.3.4.1.1 Australia Influenza Therapeutics Market by Therapy Type
8.3.4.2 China Influenza Therapeutics Market
8.3.4.2.1 China Influenza Therapeutics Market by Therapy Type
8.3.4.3 India Influenza Therapeutics Market
8.3.4.3.1 India Influenza Therapeutics Market by Therapy Type
8.3.4.4 Japan Influenza Therapeutics Market
8.3.4.4.1 Japan Influenza Therapeutics Market by Therapy Type
8.3.4.5 South Korea Influenza Therapeutics Market
8.3.4.5.1 South Korea Influenza Therapeutics Market by Therapy Type
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Influenza Therapeutics Market Overview
8.4.2 Middle East and Africa Influenza Therapeutics Market Forecasts and Analysis
8.4.3 Middle East and Africa Influenza Therapeutics Market Forecasts and Analysis - By Therapy Type
8.4.4 Middle East and Africa Influenza Therapeutics Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Influenza Therapeutics Market
8.4.4.1.1 South Africa Influenza Therapeutics Market by Therapy Type
8.4.4.2 Saudi Arabia Influenza Therapeutics Market
8.4.4.2.1 Saudi Arabia Influenza Therapeutics Market by Therapy Type
8.4.4.3 U.A.E Influenza Therapeutics Market
8.4.4.3.1 U.A.E Influenza Therapeutics Market by Therapy Type
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Influenza Therapeutics Market Overview
8.5.2 South and Central America Influenza Therapeutics Market Forecasts and Analysis
8.5.3 South and Central America Influenza Therapeutics Market Forecasts and Analysis - By Therapy Type
8.5.4 South and Central America Influenza Therapeutics Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Influenza Therapeutics Market
8.5.4.1.1 Brazil Influenza Therapeutics Market by Therapy Type
8.5.4.2 Argentina Influenza Therapeutics Market
8.5.4.2.1 Argentina Influenza Therapeutics Market by Therapy Type
9. INDUSTRY LANDSCAPE
9.1. MERGERS AND ACQUISITIONS
9.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
9.3. NEW PRODUCT LAUNCHES
9.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
10. INFLUENZA THERAPEUTICS MARKET, KEY COMPANY PROFILES
10.1. ABBOTT
10.1.1. Key Facts
10.1.2. Business Description
10.1.3. Products and Services
10.1.4. Financial Overview
10.1.5. SWOT Analysis
10.1.6. Key Developments
10.2. SANOFI SA
10.2.1. Key Facts
10.2.2. Business Description
10.2.3. Products and Services
10.2.4. Financial Overview
10.2.5. SWOT Analysis
10.2.6. Key Developments
10.3. CSL LIMITED
10.3.1. Key Facts
10.3.2. Business Description
10.3.3. Products and Services
10.3.4. Financial Overview
10.3.5. SWOT Analysis
10.3.6. Key Developments
10.4. GLAXOSMITHKLINE PLC
10.4.1. Key Facts
10.4.2. Business Description
10.4.3. Products and Services
10.4.4. Financial Overview
10.4.5. SWOT Analysis
10.4.6. Key Developments
10.5. DAIICHI SANKYO CO., LTD.
10.5.1. Key Facts
10.5.2. Business Description
10.5.3. Products and Services
10.5.4. Financial Overview
10.5.5. SWOT Analysis
10.5.6. Key Developments
10.6. ROCHE HOLDING AG
10.6.1. Key Facts
10.6.2. Business Description
10.6.3. Products and Services
10.6.4. Financial Overview
10.6.5. SWOT Analysis
10.6.6. Key Developments
10.7. BIOCRYST PHARMACEUTICALS, INC.
10.7.1. Key Facts
10.7.2. Business Description
10.7.3. Products and Services
10.7.4. Financial Overview
10.7.5. SWOT Analysis
10.7.6. Key Developments
10.8. SINOVAC BIOTECH LTD.
10.8.1. Key Facts
10.8.2. Business Description
10.8.3. Products and Services
10.8.4. Financial Overview
10.8.5. SWOT Analysis
10.8.6. Key Developments
10.9. MITSUBISHI TANABE PHARMA CORPORATION
10.9.1. Key Facts
10.9.2. Business Description
10.9.3. Products and Services
10.9.4. Financial Overview
10.9.5. SWOT Analysis
10.9.6. Key Developments
11. APPENDIX
11.1. ABOUT THE INSIGHT PARTNERS
11.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott
2. Sanofi SA
3. CSL Limited
4. Glaxosmithkline PLC
5. Daiichi Sankyo Co., Ltd.
6. Roche Holding AG
7. Biocryst Pharmaceuticals, Inc.
8. Sinovac Biotech Ltd.
9. Mitsubishi Tanabe Pharma Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..